查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602654

脱髮症治疗药物市场：按脱髮症类型、性别、给药途径分类 - 全球预测 2025-2030

Alopecia Drugs Market by Alopecia Types (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Gender (Men, Women), Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

脱髮症治疗药物市场2023年估值为12.3亿美元，预计到2024年将达到13.7亿美元，复合年增长率为11.90%，到2030年将达到27亿美元。

脱髮症治疗市场包括用于治疗脱发病症（例如脱髮症、雄性秃和脱髮症扩张）的药物。这些药物包括米诺地尔等局部药物、Finasteride等口服药物以及 JAK 抑制剂等新产品。脱髮对心理和心理的影响以及不同人群脱髮症盛行率的增加强调了对这些药物的需求。治疗目标范围从皮肤病学目的到美容增强，主要最终用户包括个人消费者、皮肤科诊所和专门的头髮治疗中心。

主要市场统计
基准年[2023] 12.3亿美元
预测年份 [2024] 13.7亿美元
预测年份 [2030] 27亿美元
复合年增长率（%） 11.90%

该市场的成长主要是由于人们对脱髮治疗的认识和接受程度的提高、药物研究的技术进步以及容易脱髮的老年人口的增加而推动的。电子商务平台的扩张也透过提高产品的可用性来推动市场渗透。此外，最近的发展凸显了再生医学和生技药品用于长期治疗脱髮症的机会。公司可以利用基因治疗和个人化医疗领域不断扩大的研究，在分子层面解决特定的脱髮症类型。

然而，市场面临先进治疗方法的高成本、潜在的副作用以及延迟药物核准的严格监管要求等挑战。此外，市场成长受到与脱髮相关的社会文化耻辱的限制，这阻碍了一些消费者寻求治疗。此外，线上仿冒品对消费者和值得信赖的製造商都构成风险。

随着经皮吸收贴片和微针等侵入性较小的药物传递方法的发展，创新可能会蓬勃发展。对脱髮症的遗传学研究可能会带来标靶治疗的突破。这个以药品和消费品为导向的市场的性质表明，製药公司需要与化妆品品牌进行协同效应，以确保治疗既有效又对使用者有吸引力。

市场动态：快速发展的脱髮症治疗市场的主要市场洞察

供需的动态交互作用正在改变脱髮症药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球自体免疫疾病流行
    • 不健康的生活方式和缺乏运动的现象正在增加
    • 更多非政府组织提高人们对脱髮症的认识
  • 市场限制因素
    • 对脱髮症治疗药物及其有效性的不良健康影响的担忧
  • 市场机会
    • 新监管机构核准脱髮症的新型系统治疗方法
    • 加速脱髮症管理的研发活动
  • 市场挑战
    • 人们越来越偏好植髮和美容治疗

波特的五力：驾驭脱髮症药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解脱髮症治疗药物市场的外部影响

外部宏观环境因素在塑造脱髮症治疗药物市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解脱髮症治疗药物市场的竞争状况

对脱髮症治疗药物市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵脱髮症治疗市场供应商的绩效评估

FPNV 定位矩阵是评估脱髮症治疗药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘脱髮症治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，脱髮症治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球自体免疫疾病盛行率增加
      • 不健康的生活方式和缺乏运动的现象正在增加
      • 更多非政府组织提高人们对脱髮症的认识
    • 抑制因素
      • 对脱髮症治疗药物对健康的不良影响和功效的担忧
    • 机会
      • 新监管机构核准脱髮症新系统治疗方法
      • 加速脱髮症治疗的研究和开发
    • 任务
      • 对头髮生长和美容疗程的兴趣正在迅速增加
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按脱髮症类型分類的脱髮症治疗药物市场

  • 脱髮症
  • 全脱髮症
  • 全身性脱髮症

第七章脱髮症治疗药物市场性别

  • 男性
  • 女士

第八章脱髮症治疗药物市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第九章 北美和南美脱髮症治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太脱髮症治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的脱髮症治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • FDA核准辉瑞公司脱髮症治疗药物
    • Sun Pharma 将以 5.76 亿美元收购美国Concert Pharmaceuticals
    • FDA核准公司和 Insight 的Olumiant（Baricitinib）作为第一个也是唯一一个治疗成人严重脱髮症的全身治疗药物
  • 战略分析和建议

公司名单

  • AndroScience Corporation
  • Capillus, LLC by Curallux, LLC
  • Cipla Inc.
  • Concert Pharmaceuticals, Inc.
  • Daiichi Sankyo Company, Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Hairline Co.
  • Merck & Co., Inc.
  • The Himalaya Drug Company
  • Vitabiotics Ltd.
Product Code: MRR-436901065B9F

The Alopecia Drugs Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.37 billion in 2024, and is projected to grow at a CAGR of 11.90%, to USD 2.70 billion by 2030.

The alopecia drugs market encompasses pharmaceuticals designed to treat hair loss conditions such as alopecia areata, androgenetic alopecia, and telogen effluvium. These medications include topical treatments like minoxidil, oral medications like finasteride, and newer entrants like JAK inhibitors. The necessity for these drugs is underscored by the emotional and psychological impacts of hair loss, coupled with the rising incidence of alopecia across diverse demographics. Applications extend from dermatological purposes to cosmetic enhancements, with key end-users including individual consumers, dermatology clinics, and specialty hair treatment centers.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.37 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 11.90%

Growth in this market is primarily driven by increasing awareness and acceptance of hair loss treatments, technological advancements in pharmaceutical research, and a growing geriatric population who are more susceptible to hair thinning. The expansion of e-commerce platforms also aids market penetration by making products more accessible. Moreover, recent developments highlight opportunities in regenerative medicine and biologics, catering to the long-term management of alopecia conditions. Companies could capitalize on expanding research into gene therapy and personalized medicine, addressing specific alopecia types at a molecular level.

However, the market faces challenges such as high costs of advanced treatments, potential side effects, and stringent regulatory requirements that delay drug approvals. Additionally, market growth is limited by the socio-cultural stigma associated with hair loss that deters some consumers from seeking treatment. Furthermore, counterfeit products online pose a risk to both consumers and credible manufacturers.

Innovation can thrive in the development of less invasive delivery methods for drugs, such as transdermal patches and microneedles, which could enhance therapeutic outcomes and consumer acceptance. Research into understanding the genetics of alopecia offers potential breakthroughs in targeted therapies. The nature of this market, being both drug and consumer goods-oriented, suggests a need for pharmaceutical companies to synergize with cosmetic brands, ensuring treatments are both effective and appeal aesthetically to users.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alopecia Drugs Market

The Alopecia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of autoimmune diseases across the globe
    • Surging adoption of unhealthy lifestyles and physical inactivity
    • Increasing number of NGOs to create awareness about alopecia condition
  • Market Restraints
    • Adverse health impact of alopecia drugs and concern with drugs efficacy
  • Market Opportunities
    • Emerging regulatory approvals for the novel systemic treatment for alopecia areata
    • Accelerating research and developments activities for alopecia management
  • Market Challenges
    • Surge in preference for the hair growth transplant and cosmetic treatment

Porter's Five Forces: A Strategic Tool for Navigating the Alopecia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alopecia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alopecia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alopecia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alopecia Drugs Market

A detailed market share analysis in the Alopecia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alopecia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alopecia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alopecia Drugs Market

A strategic analysis of the Alopecia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Drugs Market, highlighting leading vendors and their innovative profiles. These include AndroScience Corporation, Capillus, LLC by Curallux, LLC, Cipla Inc., Concert Pharmaceuticals, Inc., Daiichi Sankyo Company, Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Hairline Co., Merck & Co., Inc., The Himalaya Drug Company, and Vitabiotics Ltd..

Market Segmentation & Coverage

This research report categorizes the Alopecia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Alopecia Types, market is studied across Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
  • Based on Gender, market is studied across Men and Women.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of autoimmune diseases across the globe
      • 5.1.1.2. Surging adoption of unhealthy lifestyles and physical inactivity
      • 5.1.1.3. Increasing number of NGOs to create awareness about alopecia condition
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse health impact of alopecia drugs and concern with drugs efficacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging regulatory approvals for the novel systemic treatment for alopecia areata
      • 5.1.3.2. Accelerating research and developments activities for alopecia management
    • 5.1.4. Challenges
      • 5.1.4.1. Surge in preference for the hair growth transplant and cosmetic treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alopecia Drugs Market, by Alopecia Types

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis

7. Alopecia Drugs Market, by Gender

  • 7.1. Introduction
  • 7.2. Men
  • 7.3. Women

8. Alopecia Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Topical

9. Americas Alopecia Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Alopecia Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Alopecia Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. FDA Approves Pfizer's Alopecia Drug
    • 12.3.2. Sun Pharma to acquire US-based Concert Pharmaceuticals for USD 576 million
    • 12.3.3. FDA Approves Lilly and Incyte's OLUMIANT (baricitinib) As First and Only Systemic Medicine for Adults with Severe Alopecia Areata
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AndroScience Corporation
  • 2. Capillus, LLC by Curallux, LLC
  • 3. Cipla Inc.
  • 4. Concert Pharmaceuticals, Inc.
  • 5. Daiichi Sankyo Company, Ltd.
  • 6. Dr. Reddy's Laboratories Ltd.
  • 7. Eli Lilly and Company
  • 8. Hairline Co.
  • 9. Merck & Co., Inc.
  • 10. The Himalaya Drug Company
  • 11. Vitabiotics Ltd.

LIST OF FIGURES

  • FIGURE 1. ALOPECIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALOPECIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY MEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY WOMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALOPECIA DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ALOPECIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ALOPECIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ALOPECIA TYPES, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM ALOPECIA DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. ALOPECIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. ALOPECIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023